Correction of the spontaneous and DEB-induced chromosomal aberrations in Fanconi anemia cells of the FA(C) complementation group by the FACC gene

被引:2
|
作者
Stavropoulos, DJ
Sood, S
Tomkins, DJ
Buchwald, M
机构
[1] MCMASTER UNIV,DEPT PEDIAT,HAMILTON,ON L8N 3Z5,CANADA
[2] MCMASTER UNIV,DEPT BIOL,HAMILTON,ON L8N 3Z5,CANADA
[3] MCMASTER UNIV,DEPT PATHOL,HAMILTON,ON L8N 3Z5,CANADA
[4] HOSP SICK CHILDREN,RES INST,TORONTO,ON M5G 1X8,CANADA
[5] UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA
来源
CYTOGENETICS AND CELL GENETICS | 1996年 / 72卷 / 2-3期
关键词
D O I
10.1159/000134187
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Fanconi anemia (FA) cells are hypersensitive to the cytotoxic and clastogenic effects of DNA cross-linking agents. Four complementation groups have been identified to date. The gene (FACC) that corrects the hypersensitivity of one of them, FA(C), has been cloned. In the present study, both the increased spontaneous and diepoxybutane (DEB)-induced chromosomal instability in FA(C) lymphoblastoid cells were corrected by transfection of FACC.
引用
收藏
页码:194 / 196
页数:3
相关论文
共 50 条
  • [21] Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2
    Godthelp, Barbara C.
    van Buul, Paul P. W.
    Jaspers, Nicolaas G. J.
    Elghalbzouri-Maghrani, Elhaam
    van Duijn-Goedhart, Annemarie
    Arwert, Fre
    Joenje, Hans
    Zdzienicka, Malgorzata Z.
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2006, 601 (1-2) : 191 - 201
  • [22] Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transfer
    Fu, KL
    Lo Ten Foe, JR
    Joenje, H
    Rao, KW
    Liu, JM
    Walsh, CE
    BLOOD, 1997, 90 (09) : 3296 - 3303
  • [23] Novel Manufacturing of Gene Corrected Autologous Blood Stem Cells for Gene Therapy of Fanconi Anemia Complementation Group A
    Adair, Jennifer E.
    Chandrasekaran, Devikha
    Kubek, Sara
    Haworth, Kevin G.
    Becker, Pamela S.
    Woolfrey, Ann E.
    Burroughs, Lauri M.
    Kiem, Hans-Peter
    MOLECULAR THERAPY, 2017, 25 (05) : 40 - 41
  • [24] ON THE LOCALIZATION OF MITOMYCIN C-INDUCED ABERRATIONS IN NORMAL HUMAN AND FANCONI ANEMIA CELLS
    SAVAGE, JRK
    REDDY, KS
    MUTATION RESEARCH, 1987, 178 (01): : 65 - 71
  • [25] Fanconi anemia complementation group C (FANCC) gene association with hereditary and sporadic renal tumors (RT).
    Sager, Rebecca A.
    Desai, Devashish
    Basin, Michael
    Jacob, Joseph M.
    Basnet, Alina
    Morris, Gloria Joan
    Spiess, Philippe E.
    Li, Roger
    Cheng, Liang
    Necchi, Andrea
    Kamat, Ashish M.
    Grivas, Petros
    Murugesan, Karthikeyan
    Pavlick, Dean C.
    Goldberg, Hanan
    Mollapour, Mehdi
    Lin, Douglas I.
    Ross, Jeffrey S.
    Bratslavsky, Gennady
    Daneshvar, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 450 - 450
  • [26] The Fanconi anemia complementation group C (FAC) gene may have a tumor suppressor function.
    Liu, JM
    Devetten, M
    Walsh, CE
    BLOOD, 1995, 86 (10) : 1884 - 1884
  • [27] Fanconi anemia complementation group C protection against oxidative stress-induced β-cell apoptosis
    Kulanuwat, Sirikul
    Jungtrakoon, Prapaporn
    Tangjittipokin, Watip
    Yenchitsomanus, Pa-Thai
    Plengvidhya, Nattachet
    MOLECULAR MEDICINE REPORTS, 2018, 18 (02) : 2485 - 2491
  • [28] The Fanconi anemia group C gene product: Signaling functions in hematopoietic cells
    Fagerlie, S
    Lensch, MW
    Pang, QS
    Bagby, GC
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (12) : 1371 - 1381
  • [29] Novel lineage depletion preserves autologous blood stem cells for gene therapy of Fanconi anemia complementation group A
    Adair, Jennifer E.
    Chandrasekaran, Devikha
    Sghia-Hughes, Gabriella
    Haworth, Kevin G.
    Woolfrey, Ann E.
    Burroughs, Lauri M.
    Choi, Grace Y.
    Becker, Pamela S.
    Kiem, Hans-Peter
    HAEMATOLOGICA, 2018, 103 (11) : 1806 - 1814
  • [30] Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC)
    Liu, JM
    Kim, S
    Read, EJ
    Futaki, M
    Dokal, I
    Carter, CS
    Leitman, SF
    Pensiero, M
    Young, NS
    Walsh, CE
    HUMAN GENE THERAPY, 1999, 10 (14) : 2337 - 2346